Community Oncology Global Congress 2026

Community Oncology Global Congress 2026

The Community Oncology Global Congress 2026 is an international virtual congress dedicated to advancing cancer care in community settings around the world. The event will bring together community oncologists, multidisciplinary cancer care professionals, healthcare leaders, researchers, patient advocates, and policymakers to discuss the real-world challenges and opportunities shaping oncology care beyond major academic centers.

Community oncology plays a critical role in cancer care delivery. For many patients, community-based oncology practices are the first and most important point of access to diagnosis, treatment, follow-up care, survivorship support, and palliative services. These settings are often where patients build long-term relationships with their care teams and where many practical decisions about cancer treatment are made.

The Community Oncology Global Congress 2026 will provide a platform for experts from different regions to share their experiences, highlight local and global barriers, and discuss strategies that can improve cancer outcomes for patients in their communities.

Event Details

Date: August 28-30, 2026
Format: Virtual Congress
Live Streaming:  YouTube | X

About the Congress

The congress is designed to highlight the essential role of community oncology in improving access, quality, equity, and continuity of cancer care. Through expert-led sessions, regional perspectives, and multidisciplinary discussions, the program will explore how community-based cancer care can be strengthened across diverse healthcare environments.

The event will focus on practical topics that directly affect oncology professionals and patients, including access to timely diagnosis, treatment delivery, patient navigation, multidisciplinary collaboration, workforce development, survivorship care, palliative care, cancer prevention, and the use of digital tools in community oncology.

By bringing together experts from different countries and healthcare systems, the congress aims to encourage meaningful dialogue and support the development of adaptable solutions that can improve cancer care in community settings worldwide.

 

Scientific Leadership

Community Oncology Global Congress 2026

Jasmine Kamboj – USA, Minnesota

Community Oncologist and Hematologist, Mayo Clinic
Board Member, Minnesota Society of Clinical Oncology
Co-lead CoP Policy, ASCO.

Community Oncology Global Congress 2026
Foluke Sarimiye – Nigeria

Radiation and Clinical Oncologist / Community Oncologist and Psycho-Oncologist University of Ibadan / University College Hospital, UCH Ibadan, Nigeria Co-founder and Executive Director, Patela Care Foundation

Community Oncology Global Congress 2026
Felipe Roitberg – Brazil

Medical Oncologist, Brazil Founder and Director, Grupo SOnHe – Oncology and Hematology Services Leader in Community Oncology, Cancer Care Delivery, and Multidisciplinary Oncology Practice in Latin America.

Community Oncology Global Congress 2026
Joanna Metzner-Sadurski – USA, South Carolina

Community Medical Oncologist and Hematologist, Self Regional Healthcare,
USA Founder and Executive Director, Oncology101.org
Advocate for Community Oncology, Clinical Research, and Patient Education.

Community Oncology Global Congress 2026
Amol Akhade – India

Medical and Hemato-Oncologist with over 18 years of experience in cancer care
Trained at Tata Memorial Hospital, Mumbai
Focused on personalized cancer treatment approaches and innovative therapies

Community Oncology Global Congress 2026

Debra Patt – USA, Texas

Executive Vice President at Texas Oncology, practicing oncologist and breast cancer specialist in Austin. She serves as Medical Director for Public Policy at The US Oncology Network, President of the Community Oncology Alliance, and a board member of American Society of Clinical Oncology. Her work focuses on cancer care access, healthcare policy, AI, and digital innovation in oncology.

Speakers

ImagesName
Community Oncology Global Congress 2026

Janet L. Abrahm - USA, Massachusetts


Professor of Medicine, Harvard Medical School Pioneer in supportive and palliative oncology Founder, Palliative Care Service, Dana-Farber Cancer Institute and Brigham and Women’s Hospital Author of Comprehensive Guide to Supportive and Palliative Care for Cancer Patients.
Community Oncology Global Congress 2026

Katie Alexander - USA, Ohio


Adult-Gerontology Acute Care Nurse Practitioner specializing in adult oncology care Advanced Practice Provider Coordinator, American Oncology Network Oncology APP, Mark H. Zangmeister Cancer Center Focused on APP onboarding, education, and professional development.
Community Oncology Global Congress 2026

Alice Indini - Italy 


Medical Oncologist specializing in melanoma, cancer immunotherapy, and AYA oncology International melanoma researcher with over 100 peer-reviewed publications Focused on melanoma biology, immunotherapy response, survivorship care, and immune-related toxicities Involved in international oncology education, ESMO initiatives, and mentorship programs for young oncologists.
Community Oncology Global Congress 2026

Jeanine Frances Ewing - USA, Florida


Clinical Oncology Pharmacist, Florida Cancer Specialists Board Certified Oncology Pharmacist Specialist in oncology formulary management, evidence-based pharmacy practice, and multidisciplinary cancer care Speaker and consultant in oncology pharmacy education, guideline development, and clinical decision support.
Community Oncology Global Congress 2026

Korede Akindele - Nigeria 


Chief Operating Officer, The Dorcas Cancer Foundation Global Child Health Leader, Health Systems Strategist, and Implementation Science Specialist Former Board Member, International Society of Paediatric Oncology Former Chair, Young SIOP Network Focused on childhood cancer control, early diagnosis, treatment access, survivorship, and health systems strengthening.
Community Oncology Global Congress 2026

Mohana Murali Kolluri - India 


Consultant Radiation Oncologist, Trinity Hospitals, Kakinada, India Specialist in advanced radiotherapy techniques, including IMRT, VMAT, IGRT, SBRT, and brachytherapy Focused on gastrointestinal and head and neck cancers, clinical research, cancer education, and evidence-based cancer awareness.
Community Oncology Global Congress 2026

Raghad Abdul Karim - USA, Texas


Hematologist-Oncologist, NOVA Oncology Clinical researcher with contributions to over 60 clinical studies Focused on precision oncology, clinical trials, underserved communities, and patient-centered oncology care.
Community Oncology Global Congress 2026

Ruiling Yuan - USA, South Carolina


Board-certified Medical Oncologist and Hematologist, Self Regional Healthcare Dyad Director, Cancer Service Line, Self Regional Healthcare Clinical Assistant Professor, Medical University of South Carolina Board Member, South Carolina Oncology Society Representative, ASCO State Affiliate Council and ASCO PAC Advisory Council Focused on community and rural cancer care, health policy, survivorship, patient access, and health literacy.
Community Oncology Global Congress 2026

Vinona Bhatia - USA, California


Vinona Bhatia Hematologist-Oncologist, Healthcare Operator, and Investor Founder, Partnering for Cancer Innovation Venture Partner, Cancer Fund Advisor and LP, How Women Invest and Coyote Ventures Focused on precision oncology, biomarker-driven care, health equity, clinical strategy, and cancer care innovation.
Jenny Ahlstrom

Jenny Ahlstrom - USA, Utah 


Cancer Patient Advocate and Healthcare Innovation Leader
Founder and Chief Executive Officer, HealthTree Foundation
Leader in Multiple Myeloma Advocacy, Patient-Owned Health Data, Personalized Patient Education, Cancer Research Acceleration, Digital Health Innovation, Community Support, and Patient Empowerment

Seema Harichand-Herdt

Seema Harichand-Herdt - USA, Iowa 


Medical Oncologist and Hematologist, Mission Cancer + Blood Community Oncology Leader Focused on breast cancer care, clinical research, and patient-centered cancer care delivery.
Community Oncology Global Congress 2026

Lara Briseño Kenney - New Zealand 


Medical Oncologist and Hematologist, United States Founder, Leeton Medical Leader in rural oncology, hematology, palliative care, and community-based cancer care Focused on expanding access to direct specialty care and improving cancer care delivery in underserved settings.
Community Oncology Global Congress 2026

Jahan Aghalar - USA, New York


Medical Oncologist and Hematologist, New York Cancer & Blood Specialists Leader in genitourinary oncology and community-based cancer care Focused on patient-centered hematology and oncology practice in the community setting.
Community Oncology Global Congress 2026

Reham Abdel-Wahab - United Arab Emirates


Medical Oncologist and Clinical Researcher, Cleveland Clinic Leader in clinical and translational cancer research Focused on cancer clinical trials, immuno-oncology, real-world data, and global oncology collaborations Dedicated to advancing evidence-based cancer care through innovative research and international partnerships.
Community Oncology Global Congress 2026

Fernando Maciel Barbosa - USA, Iowa


Medical Oncologist and Clinical Associate Professor, University of Iowa Health Care Specialist in genitourinary oncology, including prostate, bladder, and kidney cancers Focused on clinical research, cancer clinical trials, and equitable access to high-quality oncology care.
Community Oncology Global Congress 2026

Anjali Sibley - USA, California


Medical Oncologist and Hematologist, Stanford Medicine Cancer Center in Emeryville Clinical Associate Professor of Medicine, Stanford School of Medicine Director, Stanford Medicine Cancer Center in Emeryville Leader in community-based oncology Focused on cancer survivorship, health equity, clinical trial access, and patient-centered cancer care.
Community Oncology Global Congress 2026

Adil Iqbal - India 


Senior Consultant Surgical Oncology Expert in gastrointestinal, breast, and thoracic cancers Specialist in complex cancer surgery and patient-centered surgical care.
Community Oncology Global Congress 2026

Sergio Contreras Garduño - Mexico 


Medical Oncologist, Mexico City, Mexico Specialist in solid tumors and hematologic malignancies Focused on evidence-based, patient-centered oncology and individualized treatment planning.
Community Oncology Global Congress 2026

Jose W. Avitia - USA, New Mexico


Medical Oncologist and Hematologist, Albuquerque and Gallup, New Mexico Board-certified in Medical Oncology and Internal Medicine Focused on patient-centered cancer care in diverse and rural communities.
Community Oncology Global Congress 2026

Terri Conneran - USA, North Carolina


Lung Cancer Survivor and Patient Advocate Advocate, KRAS Kickers Focused on KRAS-driven lung cancer awareness, education, community support, and research advocacy.
Community Oncology Global Congress 2026

Astriani Dwi Aryaningtyas - Indonesia 


Health advocate, psycho-oncology supporter, and cancer survivor. She is the founder of Inspirasien, a support platform that provides medical and psychological mentorship for patients and caregivers dealing with chronic and serious illnesses.
Allen M. Chen

Allen Chen - USA, California


MD, MBA, FASTRO, FACHE
Physician-Scientist and Oncology Diagnostics Leader
Vice President of Medical Affairs and Clinical Development, Oncology, BillionToOne
Leader in Translational Oncology, Next-Generation Cancer Diagnostics, Liquid Biopsy, Precision Oncology, Clinical Development, Medical Affairs, and Expanding Access to Oncology Innovation

Community Oncology Global Congress 2026

Kurt R. Oettel - USA, Wisconsin


Medical oncologist based in La Crosse, Wisconsin, affiliated with Gundersen Lutheran Medical Center and Black River Memorial Hospital. He earned his medical degree from the University of Wisconsin School of Medicine and Public Health and has over 20 years of clinical experience. He specializes in the diagnosis and treatment of cancers including lung, breast, and prostate cancer, using systemic therapies such as chemotherapy and comprehensive oncology care.
Community Oncology Global Congress 2026

Astha Thakkar - USA, North Carolina


Board-certified Hematologist-Oncologist Specialist in leukemia, lymphoma, and multiple myeloma Focused on patient-centered care and individualized treatment planning.
Community Oncology Global Congress 2026

Kashif Ali - USA, Maryland 


Board-certified Medical Oncologist and Hematologist, Maryland Oncology Hematology Specialist in gastrointestinal and pancreatic malignancies Focused on comprehensive inpatient and outpatient cancer care.
Community Oncology Global Congress 2026

Adedayo Joseph - Nigeria 


Clinical Radiation Oncologist, Healthcare Leader, and Cancer Equity Advocate
Consultant Oncologist and Research Program Director, Medserve-LUTH Cancer Center; Adjunct Lecturer, College of Medicine, University of Lagos; Founder, The Dorcas Cancer Foundation
Leader in Radiation Oncology, Lung, Brain and Pediatric Cancers, Clinical Trials, Oncology Education, Capacity Building, Health Systems Strengthening, Childhood and Adolescent Cancer Care, and Equitable Access to Cancer Services across Africa

Community Oncology Global Congress 2026

Adrian Pogacian - Romania 


Licensed clinical psychologist with advanced training in psycho-oncology. Founder of INCKA Psycho-Oncology Center, his expertise is in Coping with Cancer, Complicated Grief, Posttraumatic Growth and Meaning-Centered therapy approach.
Kashyap Patel

Kashyap Patel - USA, South Carolina 


Medical Oncologist and Community Oncology Leader
Chief Executive Officer, Carolina Blood and Cancer Care Associates; Associate Professor of Medicine, Edward Via College of Osteopathic Medicine
Leader in Community Oncology, Value-Based Cancer Care, Healthcare Policy, Cancer Health Disparities, Precision Medicine, Oncology Practice Leadership, and Equitable Access to Cancer Care

Community Oncology Global Congress 2026

Kathy Oubre - USA, California


 CEO, Pontchartrain Cancer Center Board Member, Community Oncology Alliance Co-chair, COA Drug Policy and Regulatory Affairs Committee Co-chair, Association of Value-Based Cancer Care and NCODA Oncology Institute Associate Editor, Evidence-Based Oncology Focused on community oncology leadership, value-based cancer care, drug policy, regulatory affairs, and government affairs.
Community Oncology Global Congress 2026

Anezka Ferrari - Brazil 


Clinical Oncologist, Brazil Medical Oncologist, DASA Oncology – Hospital Santa Paula, São Paulo Leader in Breast Cancer Care, Clinical Oncology, Cancer Diagnosis and Treatment, Patient-Centered Oncology Practice, and Cancer Education.
Community Oncology Global Congress 2026

Jack Hensold - USA, Montana 


Hematologist and Medical Oncologist, United States Retired Physician, Bozeman Health Cancer Center; President, Montana State Oncology Society Leader in Rural Oncology, Community-Based Cancer Care, Hematology, Medical Oncology, Cancer Care Delivery, and Access to Quality Cancer Care in Rural Communities.
Community Oncology Global Congress 2026

Clement Adebamowo - USA/Nigeria 


Cancer Epidemiologist and Global Oncology Researcher, United States / Nigeria Professor and Director, Cancer Epidemiology Division, University of Maryland School of Medicine Leader in Cancer Epidemiology, Global Oncology, Cancer Prevention, Genomics Research, Bioethics, and Cancer Control in Africa.
Community Oncology Global Congress 2026

Fredrick Chite Asirwa - Kenya 


Medical Oncologist and Hematologist, Kenya Chief Executive Officer, International Cancer Institute Leader in Global Oncology, Cancer Research, Clinical Trials, Oncology Education, Early Detection, Cancer Care Access, and Capacity Building across Sub-Saharan Africa.
Community Oncology Global Congress 2026

Anastasia Danilova - Russia 


Medical Oncologist, Russia Medical Oncologist, Moscow Comprehensive Cancer Centre 62 Leader in Breast Cancer, Lung Cancer, Real-World Oncology Research, Clinical Data, Immuno-Oncology, and Patient-Centered Cancer Care
Community Oncology Global Congress 2026

Atlal Abusanad - Saudi Arabia 


Medical Oncologist and Hematologist, Saudi Arabia Professor of Medicine and Medical Oncology, King Abdulaziz University Leader in Breast Cancer Care, Molecular Oncology, Survivorship, Oncology Workforce Wellbeing, Clinical Research, and Cancer Care Access in the Gulf Region
Community Oncology Global Congress 2026

Muhamad Alhaj Moustafa - USA, Florida


Hematologist and Medical Oncologist, United States Assistant Professor of Medicine, Mayo Clinic College of Medicine and Science; Consultant in Hematology/Oncology, Mayo Clinic Florida Leader in Lymphoma, Rare Hematologic Malignancies, Clinical Trials, Cellular Therapies, Precision Medicine, Medical Education, and Multidisciplinary Cancer Care
Pranshu Bansal

Pranshu Bansal - USA, Arizona


Medical Oncologist, United States Director, Thoracic, Head & Neck Oncology, Ironwood Cancer & Research Center Leader in Thoracic Oncology, Lung Cancer, Head and Neck Cancer, Clinical Research, Investigational Therapies, and Community-Based Cancer Care.
Ninja

Brian Grieb - USA, Tennessee 


Medical Oncologist, United States Director of GI Malignancy Research, Tennessee Oncology Leader in Gastrointestinal Oncology, Community-Based Cancer Care, Phase II and III Clinical Trials, Clinical Research Access, Translational Cancer Biology, and Rural Oncology Care
Ninja (2)

Amitabh Ray - India 


Radiation Oncologist, India Professor and Senior Consultant in Radiation Oncology, Chittaranjan National Cancer Institute Leader in Radiation Oncology, Thoracic and Genitourinary Cancers, Advanced Radiotherapy, Multidisciplinary Cancer Care, Oncology Education, and Equitable Access to Cancer Care
IMG_0490

Benda Kithaka - Kenya 


Cancer Advocate and Health Strategist, Kenya Founder and Executive Director, KILELE Health Association; Secretariat Lead, African Cervical Health Alliance Leader in Cervical Cancer Elimination, Patient Advocacy, Policy Influence, Community Mobilization, Strategic Communication, and Equitable Cancer Control across Africa
IMG_0512

Irene Chidothe-Chisale - Malawi 


Clinical and Radiation Oncologist, Malawi Chief Clinical and Radiation Oncologist, Malawi National Cancer Centre; Clinical Lecturer, Kamuzu University of Health Sciences Leader in Radiation Oncology, Genitourinary Cancers, Breast, Pediatric and Hematologic Cancer Care, Global Oncology, Capacity Building, and Equitable Cancer Care in Resource-Constrained Settings
IMG_0510

Devika Das - USA, Mississippi


Thoracic Medical Oncologist, United States Associate Director for Clinical Affairs, Cancer Institute at the University of Mississippi Leader in Thoracic Oncology, Lung Cancer Screening, Cancer Program Development, Quality and Safety, Clinical Trial Access, Community Oncology, and Equitable Patient-Centered Cancer Care
IMG_0509

Soham Banerjee - India 


Senior Consultant Genetic Counselor and Medical Geneticist, India Founder and Chairman, S B Genomics & Healthcare Solution; Head, Department of Medical Genetics and Genetic Counselling, Sharanya Super Speciality Hospital Leader in Genetic Counseling, Medical Genetics, Cancer Genetics, Rare Disease Advocacy, Rural Health Outreach, Genetic Education, and Community-Based Precision Healthcare
Ninja (4)

Abena Yeboah Aduse-Poku - Ghana


Belfast Clinical Oncologist, Ghana Directorate of Oncology, Komfo Anokye Teaching Hospital Leader in Breast, Gynecologic, Colorectal and Pediatric Cancer Care, Radiotherapy Delivery, Patient-Reported Outcomes, Oncology Education, Capacity Building, and Equitable Cancer Care in Resource-Limited Settings.
Ninja

Sola Adeleke - United Kingdom


Post-CCT Clinical Oncologist and Clinician-Scientist, United Kingdom Post-CCT in Clinical Oncology, Guy’s and St Thomas’ NHS Foundation Trust; Founder and Chief Medical Officer, Curenetics Leader in Prostate Cancer, Radiotherapy, Medical Imaging, Health AI, Cancer Treatment Response Prediction, Oncology Innovation, and Improving Access to Oncology Care in Low-Resource Settings
54

Roupen Odabashian - USA, Michigan 


Medical oncologist at Abbotsford Regional Hospital and the Founder of Meducation. AI. His work focuses on medical oncology, solid tumor care, precision oncology, artificial intelligence in oncology, medical education.
Ilya

Ilya Tsimafeyeu - Russia / USA


Medical Oncologist and Clinical Researcher Director, Bureau for Cancer Research (BUCARE) Leader in Genitourinary Oncology, Translational Research, Precision Oncology, Targeted Therapies, Immunotherapy, Biomarker-Driven Clinical Trials, Drug Development, and Global Oncology Collaboration
56

Brian Bourbeau - USA, Virginia 


Oncology Practice Health and Care Delivery Leader
Vice President of Care Delivery, American Society of Clinical Oncology
Leader in Oncology Practice Operations, Cancer Care Delivery, Quality Improvement, Payment Reform, Value-Based Oncology, Practice Health, and Access to High-Quality Cancer Care

58

Sana Al-Sukhun - Jordan


Medical Oncologist and Hematologist Director, Al Hyatt Oncology Practice; Adjunct Professor of Medical Oncology Leader in Breast Cancer, Global Oncology, Resource-Stratified Cancer Care, Medical Oncology Education, Health Equity, and Cancer Care Delivery in Low-Resource Settings
59

Yüksel Ürün - Turkiye


Medical Oncologist Professor of Medicine, Department of Medical Oncology, Ankara University School of Medicine Leader in Genitourinary Oncology, Prostate Cancer, Kidney Cancer, Testicular Cancer, Clinical Research, Real-World Evidence, Treatment Outcomes, and Medical Oncology Education
Otavio Al-Alam

Otavio Al-Alam - Brazil 


Medical Oncologist specializing in Gynecologic Oncology
Head of Phase I Clinical Trials, Hospital Moinhos de Vento
Leader in Gynecologic Oncology, Ovarian Cancer, Phase I Clinical Research, Precision Oncology, Cancer Immunotherapy, and Translational Cancer Research

60

Wajeeha Aiman - USA, New York 


Hematology and Medical Oncology Fellow Roswell Park Comprehensive Cancer Center Emerging leader in Hematologic Oncology, Medical Oncology, Clinical Research, Cancer Treatment Outcomes and Evidence-Based Cancer Care
61

Viviane Basílio - Brazil 


Clinical Oncologist at Oncologia D'Or
Clinical Oncology Fellowship at A.C. Camargo Cancer Center
Thoracic Oncology Care, Central Nervous System (CNS) Tumors, Uro-Oncology, Healthcare Disparities, Oncogeriatrics, and Palliative Care
62

Christine Pfaff - USA, Ohio 


Oncology Pharmacy and Community Oncology Leader Director of Clinical Initiatives, Community Oncology Alliance Leader in Community Oncology, Medically Integrated Pharmacy, Clinical Operations, Payment Reform, Practice Support, Oncology Education, and Access to Cancer Care Close to Home
Muna Al-Khaifi

Muna Al-Khaifi - Canada 


GP Oncologist, Breast Diagnostics and Cancer Survivorship Care, Department of Surgery, Mount Sinai Hospital; Assistant Professor, Department of Family and Community Medicine, University of Toronto; Cancer Survivorship & OncoMenopause Specialist; Leader in Breast Cancer Survivorship, Women’s Health, Patient-Centered Oncology Care, Digital Health, Oncology Education, and Cancer Survivorship Research
IMG_0633

Debanjan Kundu - India 


Clinical and Radiation Oncologist, Senior Resident in Radiation Oncology, Chittaranjan National Cancer Institute, Kolkata Leader in Precision Radiotherapy, SABR/SBRT, Adaptive Brachytherapy, Oligometastatic Disease, Radio-Immunotherapy, AI and Radiomics in Radiotherapy, and Cancer Care Delivery in Resource-Constrained Settings
IMG_0632

Darshil Shah - USA, Arizona


Medical Oncologist | Director of GI Oncology, Ironwood Cancer & Research Centers | Leader in Gastrointestinal Oncology, Community-Based Cancer Care, Phase II & III Clinical Trials | Educator, Speaker, and Advisor
IMG_0675

Benjamin Bleiberg - USA, Pennsylvania


Thoracic Medical Oncologist Hematology and Oncology Fellowship, University of Pennsylvania Leader in Thoracic Oncology, Clinical Trials, Real-World Evidence, Liquid Biopsy, Immunotherapy, Targeted Therapies, Biomarker Research, and Precision Cancer Care
Ninja (2)

Ruby Arora - USA, Illinois


Resident Physician PGY-3 Internal Medicine Resident, University of Illinois Chicago Emerging leader in Malignant Hematology, Lymphoma Clinical Research, Healthcare Disparities, Patient Advocacy, and Improving Cancer Care for Underserved Communities
Nicola Fusco

Nicola Fusco - Italy


Professor of Pathology and Molecular Pathologist Full Professor of Pathology, University of Milan; Director, Division of Pathology and Somatic Molecular Diagnostics, European Institute of Oncology Leader in Molecular Pathology, Breast Cancer Diagnostics, Digital Pathology, Artificial Intelligence in Healthcare, Liquid Biopsy, Precision Oncology, and Translational Cancer Research
Manojkumar Bupathi

Manojkumar Bupathi - USA, Colorado


Medical Oncologist President, Rocky Mountain Cancer Centers Leader in Genitourinary Oncology, Kidney, Bladder, Prostate and Testicular Cancers, Community-Based Cancer Care, Clinical Research, Health Equity, and Oncology Practice Leadership
Esther Chong

Esther G. Chong - USA, Oregon


Medical Oncologist and Breast Cancer Specialist
Assistant Professor, Knight Cancer Institute, Oregon Health & Science University
Leader in Breast Cancer Care, Cancer Survivorship, Long-Term Treatment Outcomes, Quality of Life, and Patient-Centered Oncology Care
Glenn Balasky

Glenn Balasky - USA, Colorado


Community Oncology Executive and Practice Operations Leader Executive Director, Rocky Mountain Cancer Centers Leader in Community Oncology, Practice Management, Value-Based Cancer Care, Oncology Payment Reform, Patient Access, Healthcare Policy, and Cancer Care Delivery
Martina Carullu

Martina Carullo - Italy


Medical Oncologist and Oncology PhD Candidate University of Pisa; Colorectal Cancer Unit, University Hospital of Pisa Emerging Leader in Gastrointestinal Oncology, Colorectal Cancer, Translational Research, Immunotherapy, Liquid Biopsy, AI-Powered Biomarkers, and Precision Oncology
Linda Bosserman

Linda Bosserman - USA, California


Medical Oncologist and Breast Cancer Specialist Professor, Department of Medical Oncology & Therapeutics Research; Medical Director, Value-Based Care and Center for International Medicine, City of Hope Leader in Breast Cancer, Sexual Health in Cancer Care, Oncology Pathways, Value-Based Care, International Oncology, Survivorship, and Patient-Centered Cancer Care
Malu Barbosa

Malu Barbosa - Canada/Brazil


Medical Oncologist Medical Oncology Clinical Fellow, Sunnybrook Health Sciences Centre; University of Toronto Emerging Leader in Thoracic Oncology, Lung Cancer, Immunotherapy, Clinical Research, Real-World Evidence, Precision Oncology, and International Oncology Collaboration
Mohamed Alsharedi

Mohamed Alsharedi - USA, Kentucky


Hematologist and Medical Oncologist Hematology/Oncology, Markey Cancer Center at Lexington Clinic Leader in Hematology, Medical Oncology, Community-Based Cancer Care, Multidisciplinary Oncology, and Access to Advanced Cancer Treatment in Kentucky
Simon Blanc

Simon Blanc- USA, Florida


Hematologist and Medical Oncologist Cancer Center Director, Broward Health Leader in Community Oncology, Hematologic and Solid Tumor Malignancies, Precision Oncology, Real-World Evidence, Clinical Research, Health Equity, and Access to Advanced Cancer Care
Victor Chiu

Victor Chiu - USA, Arizona


Hematologist and Medical Oncologist Assistant Chief Medical Officer, Ironwood Cancer & Research Centers Leader in Breast Oncology, Skin Cancer, Sarcoma, Hematologic Disorders, Precision Medicine, Immunotherapy, Clinical Trials, and Community-Based Cancer Care
Christine Verini

Christine Verini - USA, New York


Cancer Patient Advocacy and Nonprofit Healthcare Executive Chief Executive Officer, CancerCare Leader in Cancer Patient Support, Patient Advocacy, Psychosocial Oncology Services, Health Equity, Nonprofit Leadership, Mission-Based Programs, and Access to Cancer Care
Jonathan Ticku

Jonathan Ticku - USA, Wisconsin


Hematologist and Medical Oncologist Assistant Professor of Oncology and GU Oncology Lead, Mayo Clinic Health System Leader in Community and Rural Oncology, Genitourinary and Thoracic Oncology, Hematologic Malignancies, Breast Cancer Care, Virtual Oncology, and Access to Advanced Cancer Therapies Close to Home
Michael Crosby

Michael Crosby - USA, California


Prostate Cancer Advocate and Patient Education Leader Ambassador and Board Member, Oncidium Foundation USA; Founder and CEO, Veterans Prostate Cancer Awareness Leader in Prostate Cancer Advocacy, Veteran Health, Patient Education, Molecular Imaging, Nuclear Medicine, Radioligand Therapy Awareness, and Access to Precision Cancer Care
Oluseyi Abidoye

Oluseyi Abidoye - USA, Arizona


Hematology and Medical Oncology Fellow Mayo Clinic Comprehensive Cancer Center, Phoenix Emerging Leader in Gastrointestinal Oncology, Precision Oncology, Liquid Biopsy, Biomarker-Driven Research, Clinical Trials, and Evidence-Based Cancer Care
Qasim Mahmood Buttar

Qasim Mahmood Buttar - Pakistan


Medical Oncologist Professor of Medical Oncology, Pakistan Institute of Medical Sciences; Consultant Medical Oncologist, Kulsum International Hospital Leader in Medical Oncology, Hematologic Malignancies, Solid Tumor Care, Clinical Research, Community-Based Oncology, and Cancer Care Delivery in Resource-Constrained Settings
Marc Braunstein

Marc Braunstein - USA, New York


Hematologist and Medical Oncologist
Associate Professor of Medicine, NYU Grossman Long Island School of Medicine; Program Director, Hematology/Oncology Fellowship; Co-Director, Hematology Organ System; Vice President, Faculty Council
Leader in Multiple Myeloma, Plasma Cell Disorders, Amyloidosis, Hematologic Malignancies, Stem Cell Transplantation, CAR T-Cell Therapy, Clinical Trials, and Personalized Hematologic Cancer Care.

Noha Rashad

Noha Rashad - Egypt


Medical Oncologist
Medical Oncology Department, Suez University; Medical Oncology Consultant and Chair, Gastrointestinal Malignancies Interest Group, Shefa Al-Orman Comprehensive Cancer Center and Hospital
Leader in Gastrointestinal Oncology, Neuroendocrine Tumors, Cancer Screening and Early Detection, Colorectal Cancer, Clinical Research, Critical Appraisal, and Cancer Care in Egypt

Imene Hadji

Imène Hadji - Algeria


Medical Oncologist and Global Oncology Advocate
Medical Oncologist, Department of Medical Oncology, EPH Ain El Berda, Annaba; Lead, OncoDaily Algeria Hub
Leader in Global Oncology, Equitable Cancer Care, Oncology Capacity Building, Real-World Cancer Research, Health Disparities, International Collaboration, and Oncology Education in Resource-Limited Settings

Fred Ashbury

Fred Ashbury - United States, Colorado


BA, MA, PhD, FMASCC
Cancer Care Researcher and Supportive Oncology Leader
Chief Scientific Officer, VieCure; Adjunct Professor, University of Calgary and The Ohio State University; Editor-in-Chief, Supportive Care in Cancer
Leader in Supportive and Psychosocial Oncology, Cancer Care Quality, Clinical Guidelines, Oncology Research, Evidence-Based Practice, and Patient-Centered Cancer Care

Angelina Lorello

Angelina Lorello - United States, New York


Patient Experience and Community Oncology Advocate
Patient Experience, New York Cancer & Blood Specialists; CPAN Leader; Leader, Patient and Family Council
Advocate whose personal story with community oncology inspires her work in patient experience, storytelling, and amplifying patient and caregiver voices


Tuat Huynh

Tuat Huynh - Vietnam


Medical Oncologist and Clinical Researcher
Medical Oncology Department, Oncology Center, Hue Central Hospital
Leader in Head and Neck Cancer, Urogynecologic Cancers, Hepatobiliary-Pancreatic Cancers, Digital Oncology, AI in Oncology, Radiomics Research, Early Clinical Trials, and Advancing Cancer Care in Vietnam


The program will explore how community oncology teams can improve care coordination, strengthen patient-centered treatment, reduce disparities, and expand access to high-quality cancer care outside major academic centers.

Who Should Attend

This congress is designed for community oncologists, medical oncologists, hematologists, radiation oncologists, surgical oncologists, oncology nurses, oncology pharmacists, palliative care professionals, patient advocates, healthcare administrators, researchers, policymakers, representatives of cancer organizations, and all professionals involved in improving cancer care delivery in community settings.

Why Attend

The Community Oncology Global Congress 2026 will provide a platform for international experts and frontline oncology professionals to discuss how cancer care is delivered outside major academic centers and how community-based care can be strengthened.

Participants will gain practical insights from diverse regions, learn from real-world experiences, and join a global conversation focused on improving access, quality, equity, and outcomes for patients with cancer.